Article Information
History
- November 13, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Gaia Meonia,b,¶,
- Veronica Ghinia,c,¶,
- Laura Maggid,
- Alessia Vignolia,c,
- Alessio Mazzonid,
- Lorenzo Salvatid,
- Manuela Caponed,
- Anna Vannid,
- Leonardo Tenoria,e,
- Paolo Fontanarif,
- Federico Lavorinid,g,
- Adriano Perish,
- Alessandro Bartolonid,i,
- Francesco Liottad,j,
- Lorenzo Cosmid,j,
- Claudio Luchinata,e,
- Francesco Annunziatod,k,* and
- Paola Turanod,e,*
- aMagnetic Resonance Center (CERM), University of Florence, 50019, Sesto Fiorentino, FI, Italy
- bGiotto Biotech srl, 50019, Sesto Fiorentino, FI, Italy
- cConsorzio Interuniversitario Risonanze Magnetiche di Metallo Proteine (CIRMMP), University of Florence, 50019, Sesto Fiorentino, FI, Italy
- dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
- eDepartment of Chemistry “Ugo Schiff”, University of Florence,50019 Sesto Fiorentino, FI, Italy
- fCardiac Anaesthesia and Intensive Care Unit, Careggi University Hospital, 50134, FI, Italy
- gPneumology and Intensive Care Unit, Careggi University Hospital, 50134, FI, Italy
- hIntensive Care Unit and Regional ECMO Referral Centre, Careggi University Hospital, 50134, FI, Italy
- iInfectious and Tropical Diseases Unit, Careggi University Hospital, 50134, FI, Italy
- jImmunology and Cell Therapy Unit, Careggi University Hospital, 50134, FI, Italy
- kFlow Cytometry Diagnostic Center and Immunoterapy (CDCI), Careggi University Hospital, 50134, FI, Italy
- ↵*Corresponding authors Paola Turano, Francesco Annunziato; Email:
turano{at}cerm.unifi.it, francesco.annunziato{at}unifi.it.
↵¶ These authors contributed equally;
Posted November 13, 2020.
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab
